C. Doyle
Chief Executive Officer chez Arxada America LLC
Profil
C. Marc Doyle est vice-président exécutif de E.I. du Pont de Nemours & Co. et membre de l'American Chemical Society et de The Electrochemical Society. Dans le passé, M. Doyle a été directeur général et administrateur de DuPont de Nemours, Inc. et président de Nutrition & Biosciences, Inc. (une filiale de DuPont de Nemours, Inc.), vice-président principal de Dupont Protection Technologies et directeur du développement commercial de DuPont iTechnologies. Il a obtenu un doctorat de l'Université de Californie, Berkeley et un diplôme de premier cycle de l'Université de Virginie.
Postes actifs de C. Doyle
Sociétés | Poste | Début |
---|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The Electrochemical Society | Corporate Officer/Principal | - |
Arxada AG
Arxada AG Chemicals: Major DiversifiedProcess Industries Arxada AG is a Swiss specialty chemicals company that offers consumer microbial control, industrial microbial control, and specialty product solutions. The company is based in Basel, CH, and has subsidiaries in the Netherlands, United States, and Thailand. The company provides a wide range of differentiated products for various end markets, including hygiene, home and personal care, wood protection, crop protection, and food, beverage, and water. Arxada has leading regulatory capabilities, IP expertise, and an established track record in the industry. C. Marc Doyle has been the CEO of the company since 2021. | Director/Board Member | 20/09/2023 |
Arxada America LLC
Arxada America LLC Pharmaceuticals: MajorHealth Technology Arxada America LLC is a private company that partners with the pharmaceutical, biotech, and specialty ingredients markets to provide solutions that improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment. The company is based in Morristown, NJ. The company offers a systematic approach to tech transfers, manufacturing, and pre-approval inspection readiness to reliably take therapies to commercialization. The company was founded by C. Marc Doyle, who has been the CEO since incorporation. | Chief Executive Officer | 01/01/2021 |
Anciens postes connus de C. Doyle
Sociétés | Poste | Fin |
---|---|---|
DUPONT DE NEMOURS, INC. | Chief Executive Officer | 17/02/2020 |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | President | - |
Dupont Protection Technologies | Corporate Officer/Principal | - |
DuPont iTechnologies | Corporate Officer/Principal | - |
E I DU PONT DE NEMOURS AND CO | Public Communications Contact | - |
Formation de C. Doyle
University of Virginia | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DUPONT DE NEMOURS, INC. | Process Industries |
Entreprise privées | 8 |
---|---|
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
DuPont iTechnologies | Electronic Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
The Electrochemical Society | |
Dupont Protection Technologies | |
Arxada AG
Arxada AG Chemicals: Major DiversifiedProcess Industries Arxada AG is a Swiss specialty chemicals company that offers consumer microbial control, industrial microbial control, and specialty product solutions. The company is based in Basel, CH, and has subsidiaries in the Netherlands, United States, and Thailand. The company provides a wide range of differentiated products for various end markets, including hygiene, home and personal care, wood protection, crop protection, and food, beverage, and water. Arxada has leading regulatory capabilities, IP expertise, and an established track record in the industry. C. Marc Doyle has been the CEO of the company since 2021. | Process Industries |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Process Industries |
Arxada America LLC
Arxada America LLC Pharmaceuticals: MajorHealth Technology Arxada America LLC is a private company that partners with the pharmaceutical, biotech, and specialty ingredients markets to provide solutions that improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment. The company is based in Morristown, NJ. The company offers a systematic approach to tech transfers, manufacturing, and pre-approval inspection readiness to reliably take therapies to commercialization. The company was founded by C. Marc Doyle, who has been the CEO since incorporation. | Health Technology |